Cannabix Technologies Provides Update on THC Breath Analyzer Development and Testing
August 13 2020 - 8:45AM
Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the
“Company or Cannabix”) developer of the Cannabix Marijuana
Breathalyzer for law enforcement and the workplace, is pleased to
report that it has been performing user testing with human subjects
in Vancouver, BC with its version 2.0 THC Breath Analyzer
(“THCBA”). The THCBA device currently provides results in under
five minutes. Cannabix has been testing the THCBA device with
positive and negative cannabis breath samples with the objective of
further training the device’s machine learning database and
optimizing components for its upcoming (more robust) version 3.0
device. In recent weeks, Company engineers have also been focusing
on device scalability, reducing device production costs, and have
tested new thermoplastic soft molded components that would allow
for higher durability, and reproducibility. Additional sensors are
being incorporated into the device that will integrate more breath
sample meta-data and will allow for device usage under a wider
range of environmental conditions. Engineers have also developed a
technique for sanitization of the device between users, and the GUI
for the device has been simplified for administrators. Many
of these improvements have been incorporated into the current
device and other improvements are scheduled to be included into a
version 3.0 device that will undergo more widespread pilot use.
Recent pictures of user testing activity with the THCBA version 2.0
are included in this press release and available on the Company’s
website at www.cannabixtechnologies.com.
The user testing procedure includes a baseline breath sample
prior to the subject smoking cannabis followed by samples taken
after smoking cannabis at multiple time points up to a minimum of 2
hours. Newly available images show how a subject interacts
with the device at various stages of use. The testing process
includes a sampling stage, an analysis stage, and the results stage
- showing when THC is detected (a positive result) and when THC is
not detected (a negative result).
The THCBA incorporates microfluidic sensor technology for the
detection of THC from breath. The Company has been developing the
THCBA with Dr. Mina Hoorfar at University of British Columbia
Okanagan campus (“UBC”) and has an exclusive technology license
agreement with UBC. Cannabix Technologies is on the forefront in
research and development to create point-of-care breath testing
technologies for the detection of ∆9-tetrahydrocannabinol (“THC”) -
the psychoactive component of marijuana that causes impairment.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a leader in marijuana breathalyzer
development for law enforcement and the workplace. Cannabix has
established breath testing technologies in the pursuit of bringing
accurate, durable, portable tools to market to enable detection of
marijuana-impaired driving offences on roads at a time when
marijuana is becoming legal in many global jurisdictions. Cannabix
is working to develop drug-testing devices that will detect THC-
the psychoactive component of marijuana that causes intoxication-
using breath samples. In particular, Cannabix is focused on
developing breath testing devices for detection of recent use of
THC, in contrast to urine testing for THC metabolite that requires
an invasive collection and reflects usage, days or even weeks
earlier. The devices will also be useful for other practical
applications such as testing employees in the workplace where
impairment by THC can be hazardous.
We seek Safe Harbor.
On behalf of the Board of Directors
“Rav Mlait”
CEOCannabix Technologies Inc.
For further information, contact the Company at
info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility for
the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Statements This
press release contains forward-looking information that involves
various risks and uncertainties regarding future events. Such
forward-looking information can include without limitation
statements based on current expectations involving a number of
risks and uncertainties and are not guarantees of future
performance of the Company, such as final development of a
commercial or prototype product(s), successful trial or pilot of
company technologies, no assurance that commercial sales of any
kind actually materialize; no assurance the Company will have
sufficient funds to complete product development. There are
numerous risks and uncertainties that could cause actual results
and the Company’s plans and objectives to differ materially from
those expressed in the forward-looking information, including: (i)
adverse market conditions; (ii) risks regarding protection of
proprietary technology; (iii) the ability of the Company to
complete financings; (iv) the ability of the Company to develop and
market its future product; and (v) risks regarding government
regulation, managing and maintaining growth, the effect of adverse
publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements
and filings. There is no assurance that the marijuana breathalyzer
business will provide any benefit to the Company, and no assurance
that any proposed new products will be built or proceed. There is
no assurance that existing “patent pending” technologies licensed
by the Company will receive patent status by regulatory
authorities. The Company is not currently selling commercial
breathalyzers. Actual results and future events could differ
materially from those anticipated in such information. These and
all subsequent written and oral forward-looking information are
based on estimates and opinions of management on the dates they are
made and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.
Photos accompanying this announcement are available
at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/ebc13a7e-1dc7-4b41-9a5c-4e34a406ebd2
https://www.globenewswire.com/NewsRoom/AttachmentNg/eb3a4104-7987-43d6-a7e2-2fed8328f6c7
Cannabix Technologies (CSE:BLO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Cannabix Technologies (CSE:BLO)
Historical Stock Chart
From Oct 2023 to Oct 2024